Top Markets
Coin of the day
Pharmadrug Inc. Pharmadrug Inc.

Pharmadrug Inc.

PHRX
Rang in aandelen #38429
Pharmadrug Inc., a Toronto-based specialty pharmaceutical firm, is dedicated to... Pharmadrug Inc., a Toronto-based specialty pharmaceutical firm, is dedicated to the research, development, and market introduction of controlled substances and natural therapeutics, such as psychedelics, cannabis, and other approved compounds derived from nature. The company also manages the import and supply of medical cannabis to pharmacies across Germany and the broader European Union. Additionally, it operates Super Smart, an entity focused on advancing the application of functional and psilocybin mushrooms, and engages in studies to reformulate established natural medicines. Pharmadrug maintains key research collaborations, including an agreement with the University of Michigan to explore the potential role of N, N-dimethyltryptamine (DMT) in various states of consciousness. It has also partnered with the Southwest Research Institute for the manufacturing of cepharanthine and entered into a clinical trial agreement with Johns Hopkins University to compare the acute and enduring psychological and neural effects of DMT against another potent active molecule. The company adopted its current name in October 2019, having previously operated as Aura Health Inc.
Aandeelprijs
$0.00733937
Marktkapitalisatie
$985.05K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-32.41%
Land
CA
Handel Pharmadrug Inc. (PHRX)

Categorie

EPS voor Pharmadrug Inc. (PHRX)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Pharmadrug Inc. is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van Pharmadrug Inc. van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten